HIGHLIGHTS
- who: Telles S and colleagues from the Patanjali Research Foundation, Haridwar, India have published the Article: 3:, in the Journal: (JOURNAL)
- future: Future Directions Hence though beneficial adverse effects of DS therapy cannot be entirely ruled out. The focus of future research should be the long term follow-up of patients undergoing DS therapy for psoriasis.
SUMMARY
Psoriasis is an inflammatory, autoimmune disease mediated by interleukin (IL)-17 producing Cluster of Differentiation 4 (CD4+) and T helper cells (Th) cells. The benefits of DS therapy in patients with psoriasis were determined . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.